Pfizer building biologics clinical manufacturing facility, hiring 75 in Andover

ANDOVER, Mass. — Pfizer Inc. broke ground for its new biologics clinical manufacturing facility in Andover, Massachusetts. Expanding the company’s presence in the state, Pfizer will invest more than $200 million in development of the 175,000 sq. ft. state-of-the-art facility that will enable the production of high-quality, complex biologics and vaccines.

The new 5-story building is expected to be operational by January 2019. Approximately 75 new employees will be hired to support clinical manufacturing. In addition to the Andover campus, Massachusetts is home to Pfizer’s Research and Development hub in Cambridge. Pfizer has approximately 2,000 employees based in Massachusetts. Check for Pfizer jobs here.

Pfizer’s Andover campus currently includes 7 buildings which house laboratories, clinical and commercial manufacturing suites, and support areas. It also includes a multiproduct manufacturing facility, which allows clinical and commercial products to be manufactured simultaneously, supporting a range of Pfizer product supply.

“This five-story building will add 75 new permanent manufacturing jobs and 200 temporary construction jobs to Pfizer’s Andover campus, already home to 1,200 employees,” Senator Barbara L’Italien said. “This project is a testament to Pfizer’s commitment to Andover and I look forward to the facility opening in early 2019.”

READ MORE of this story at Pfizer by Dean Mastrojohn.

Shared By

John Parker

John Parker is an award-winning writer whose career has led him to telling tales in locales as diverse as Oklahoma, St. Kitts-Nevis (a great place to vacation!) in the West Indies and the beautiful mountains, forests and innovation-rich environment of greater Seattle. He ...